HERON THERAPEUTICS, INC. /DE/
Profile
Company Names
HERON THERAPEUTICS, INC. /DE/
AP PHARMA INC /DE/
Addresses
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA 92121
123 SAGINAW DRIVE, REDWOOD CITY, CA 94063
Phone Numbers
858-251-4400
6503662626
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$117,192,817.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-07-25
$30,000,000.00
$30,000,000.00
$0.00
Equity
4
2012-07-30
$53,549,999.00
$53,549,999.00
$0.00
Equity
3
2011-07-01
$24,000,001.00
$24,000,001.00
$0.00
Equity
2
2011-05-02
$1,500,000.00
$4,500,000.00
$3,000,000.00
Debt
1
2009-10-22
$8,142,817.00
$16,642,811.00
$8,499,994.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN
BARR
EXECUTIVE OFFICER
PAUL
GODDARD
DIRECTOR
CRAIG
JOHNSON
DIRECTOR
CLOUD ENGINES INC
| PURE BIOSCIENCE, INC.
| FOREST CITY TRADING GROUP, LLC
| ERC ACQUISITION HOLDINGS, LLC
| HARVEST FRANCHISE FUND OFFSHORE, LTD.
| ERC GROUP HOLDINGS, LLC
| ECOVENT CORP.
| GENOMEDX BIOSCIENCES INC.
| THRIVE AGROBIOTICS, INC.
| EXOTECH BIO, INC.
| RELIEVE GENETICS, INC.
| AD SKINCARE, INC.
| CRS BIO, INC.
| GENTEN THERAPEUTICS, INC.
| REHABPULSE HOLDCO INC.
| HERON THERAPEUTICS, INC. /DE/
| COMMONWEALTH SECURITY RESOURCES, LLC
| REVOLUTION GLOBAL HEALTH, INC.
| CLOUDASTRUCTURE, INC.
KEVIN
KOTLER
DIRECTOR
ROBERT
ROSEN
DIRECTOR
LINCOLN PEAK PARTNERS, INC.
| KLS DIVERSIFIED FUND LP
| KLS DIVERSIFIED FUND LTD.
| AP PHARMA INC /DE/
| ASEKO INC.
| KLS RATES FUND LP
| KLS RATES FUND LTD.
| KLS CREDIT OPPORTUNITIES FUND LP
| CONKWEST, INC.
| NANTKWEST, INC.
| KLS MACRO RATES FUND LP
| KLS MACRO RATES FUND LTD.
| KLS SPECIAL SITUATIONS FUND A LP
| KLS SPECIAL SITUATIONS FUND B LP
| KLS STRUCTURED INCOME FUND A LP
| KLS STRUCTURED INCOME FUND B LP
| CJIP IV CO-INVESTMENT, L.P.
| CJIP V CO-INVESTMENT, L.P.
| ABINGWORTH BIOVENTURES 9 LP
| ACCD 3 COINVESTMENT, L.P.
TOBY
ROSENBLATT
DIRECTOR
GREGORY
TURNBULL
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-07-25
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-07-30
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2011-07-01
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2011-05-02
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2009-10-22

